S3V Vascular Technologies Competitors and Similar CompaniesClear all

S3V Vascular Technologies's competitors and similar companies include Zhejiang Gongdong Medical Technology, Richard Wolf, Southern Prosthetic Supplies and Midmark.

	S3V Vascular Technologies S3V Vascular Technologies is a provider of medical devices.	Zhejiang Gongdong Medical Technology Zhejiang Gongdong Medical Technology is a manufacturer and supplier of medical devices and supplies.	Richard Wolf Richard Wolf is a supplier of products and solutions for endoscopy and extracorporeal shock wave treatment.	Southern Prosthetic Supplies Southern Prosthetic Supplies (SPS) is a company that distributes orthotic and prosthetic products.	Midmark Midmark is a company that manufactures and supplies medical, dental, and veterinary equipment.
Founding Date	Founding Date 2011	Founding Date 1985	Founding Date 1906	Founding Date 1951	Founding Date 1915
Type	Type Private	Type Public	Type Private	Type Subsidiary	Type Private
Tags	Tags Healthcare medical devices	Tags Healthcare medical devices	Tags Healthcare medical devices	Tags Retail distribution medical devices	Tags Healthcare dental ecommerce medical devices veterinary
Locations	Locations Anagahalli, IN HQ	Locations Taizhou, CN HQ Riverside, US	Locations Knittlingen, DE HQ Wien, AT Gent, BE Sao Paulo, BR Beijing, CN Shanghai, CN Reims, FR see more	Locations Alpharetta, US HQ Fresno, US	Locations Versailles, US HQ Brisbane City, AU Melbourne, AU Perth, AU Sydney, AU Bruxelles, BE São Paulo, BR see more
Employees	Employees 1023% decrease	Employees 1,693	Employees 1,800	Employees 1981% increase	Employees 2,200
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥1.1b (FY, 2024)	Revenue (est.) €249.9m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) $717m (FY, 2022)
Cost of goods	Cost of goods N/A	Cost of goods ¥749.5m (FY, 2024)	Cost of goods €70.1m (FY, 2021)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ¥352.8m (FY, 2024)	Gross profit €179.7m (FY, 2021)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income ¥171.5m (FY, 2024)	Net income €4.1m (FY, 2021)	Net income N/A	Net income N/A